2024-10-31 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis:

**1. Performance Comparison:**

* **Company Overview:** Teladoc Health Inc. is a leading telehealth provider offering virtual healthcare services.
* **Cumulative Return:** TDOC has generated a cumulative return of 51.34% compared to the S&P 500 (VOO) which has returned 135.27%. This indicates that TDOC has underperformed the market significantly. 
* **Relative Divergence:** The relative divergence is -83.93, placing TDOC at the 0.25 percentile of its historical performance against the S&P 500. This signifies that TDOC has been underperforming the market for a considerable period.

**2. Recent Price Movement:**

* **Closing Price:** $8.92 (Last Market: $9.15)
* **5-Day Moving Average:** $8.79
* **20-Day Moving Average:** $9.08
* **60-Day Moving Average:** $8.16
* **Observations:** The stock is currently trading above its 5-day and 60-day moving average, but below its 20-day moving average. This suggests potential for a short-term bounce but the longer-term trend remains uncertain.

**3. Technical Indicators:**

* **RSI:** 46.5 - This suggests that the stock is neither overbought nor oversold, indicating a neutral sentiment.
* **PPO:** -1.06 - A negative PPO indicates that the stock price is below its 12-day moving average and suggests a potential for further decline.
* **Delta_Previous_Relative_Divergence:** -0.79 (-) - This signifies a short-term downward trend in relative performance.
* **Expected Return:** 0.0% - Based on current market conditions, TDOC is expected to generate 0% return over the next 2 years compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | -4.92 | 0.64 B$ |
| 2024-04-26 | -0.49 | 0.65 B$ |
| 2023-10-27 | -0.35 | 0.66 B$ |
| 2023-07-28 | -0.4 | 0.65 B$ |
| 2023-04-28 | -0.4 | 0.65 B$ |

* **Observations:** TDOC has reported consistent revenue growth over the past few quarters but is facing profitability challenges. The company is currently in a loss-making position, with the latest earnings falling below analysts' estimates. This underperformance has contributed to the stock's decline.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-06-30 | $0.64B | 70.73% |
| 2024-03-31 | $0.65B | 69.89% |
| 2023-12-31 | $0.66B | 70.72% |
| 2023-09-30 | $0.66B | 71.83% |
| 2023-06-30 | $0.65B | 70.79% |

* **Observations:** Despite steady revenue growth, TDOC's profit margin has been under pressure, indicating a potential lack of efficient cost management. 

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-06-30 | $1.50B | -55.77% |
| 2024-03-31 | $2.29B | -3.58% |
| 2023-12-31 | $2.33B | -1.24% |
| 2023-09-30 | $2.29B | -2.49% |
| 2023-06-30 | $2.30B | -2.84% |

* **Observations:** TDOC's equity has fluctuated slightly, but the company's return on equity (ROE) remains significantly negative. This reflects the company's struggles with profitability and raises concerns about long-term sustainability. 

**6. News and Recent Developments:**

* **Recent Earnings News:** TDOC's recent earnings call highlighted the company's focus on cost-cutting measures and improving profitability. Analysts are closely monitoring the company's progress in this area. 
* **Market Outlook:** While TDOC operates in a growing telehealth market, competition is fierce. The company faces challenges in achieving profitability and needs to demonstrate sustainable growth.
* **Analyst Opinions:** Many analysts are cautious about TDOC's future prospects due to its weak financials and competitive pressures. Some analysts recommend holding or selling the stock, while a few maintain a buy rating based on the long-term potential of telehealth.

**7. Overall Analysis:**

TDOC's stock has underperformed the market significantly and is currently facing challenges with profitability. The company's recent earnings report shows continued revenue growth but also highlights ongoing issues with cost management and efficiency. While the telehealth industry remains promising, TDOC's ability to improve its financial performance and gain market share remains uncertain. Investors should carefully consider these factors before making an investment decision.

**8. Conclusion:**

TDOC's recent performance and financial situation present a challenging picture for investors. While the telehealth industry holds potential for growth, TDOC's underperformance against the market and its struggles with profitability raise concerns. Investors seeking a more stable and predictable investment may want to consider other opportunities. However, those with a higher risk tolerance and a long-term perspective may consider TDOC if they believe in its future potential and its ability to address its current challenges.